July 5, 2011

Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.

July 5, 2011

APP Pharmaceuticals has received regulatory approval for the treatment of a complication related to hypothyroidism.

July 5, 2011

MediShield was selected as a winner of the 11th Annual New York Venture Summit Top Innovator award last month by YoungStartup Ventures. The award recognizes privately held companies from across the United States that play a leading role in innovation.

July 5, 2011

David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

July 5, 2011

The dietary supplement industry last week took another legislative knock to the chin as it was associated with controversy surrounding mislabled conventional foods, specifically Lazy Cakes, a brownie that contains the dietary ingredient melatonin and purports to be a dietary supplement.

July 5, 2011

The Food and Drug Administration on Tuesday published long-awaited guidance on new dietary ingredients in the Federal Register.

July 5, 2011

Eli Lilly's SVP global quality has joined the drug maker's executive committee, effective July 1.

July 5, 2011

H. D. Smith, the fourth-largest national pharmaceutical wholesaler, on Tuesday named Mark de Bruin to the post of corporate VP managed care.

July 5, 2011

The Food and Drug Administration has approved a drug made by Archimedes Pharma for treating breakthrough pain in cancer patients, Archimedes said last week.

July 5, 2011

McKesson sparked its McKesson IdeaShare Conference at the Moscone Convention Center from June 29 through July 2 with a number of programs designed to bolster the competitiveness and profitability among independent pharmacies.

July 5, 2011

Navarro Discount Pharmacy, the largest Hispanic-owned pharmacy chain in the United States and an MBF Healthcare portfolio company, has announced the opening of its 29th store in North Miami in the Arch Creek Shopping Center.

July 5, 2011

The Food and Drug Administration has approved a drug made by Novartis for treating chronic obstructive pulmonary disease, the FDA said Friday.

July 5, 2011

As part of a strategic assessment, generic drug maker Par Pharmaceutical is set to restructure its branded division.

July 5, 2011

Pfizer defended a drug used for smoking cessation Monday following reports of a Canadian study that found it raised the risk of heart problems.

July 5, 2011

ProPhase Labs on Tuesday announced that it received a letter from the NASDAQ Stock Market indicating that the company no longer is in compliance with NASDAQ listing rules because the closing bid price per share of its common stock has dropped below $1 per share for 30 consecutive trading days.

July 5, 2011

New graphic cigarette warning labels released last month by the Food and Drug Administration already appear to be having one desired effect: an increase in "quit smoking" queries to the national 1-800-QUIT-NOW smoking cessation line, the Associated Press reported Saturday.

July 5, 2011

Sagent has received approval from the Food and Drug Administration for its antibacterial drug.

July 5, 2011

Santal Solutions last week announced its dietary supplement Assurance Blood Health Support has gained distribution through Rite Aid and Walgreens.

July 5, 2011

Shire has filed patent infringement suits against two generic drug makers relating to its attention deficit hyperactivity disorder treatment.

July 5, 2011

St. Joseph Aspirin has returned to store shelves with a series of product, packaging and retail enhancements, Ilex Consumer Products Group announced last month.

July 5, 2011

Thomas Dowd has been named GNC EVP, chief merchandising officer and general manager, the company announced in a Securities and Exchange Commission filing Friday.

July 5, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating deep vein thrombosis in patients undergoing knee or hip replacement surgery, a J&J subsidiary said Friday.

June 30, 2011

Just about everybody seems satisfied with Diplomat Specialty Pharmacy’s services, according to the company’s 2011 patient satisfaction survey.

June 30, 2011

Impax Labs has agreed not to market a generic version of a drug designed to reduce blood sugar and cholesterol in tablet form until 2015.